Help to shape our future
Would you like to help shape Retina UKβs future? Do you want to ensure decision-makers understand the impact of inherited sight loss? If so weβd love to hear from you.
Search results
Would you like to help shape Retina UKβs future? Do you want to ensure decision-makers understand the impact of inherited sight loss? If so weβd love to hear from you.
Inside this edition, register now for our AI webinar on 7 December with Dr Nikolas Pontikos.
Autosomal dominant inheritance means that the faulty gene is on an autosome (any chromosome other than the sex chromosomes) and that only one faulty copy is needed to cause sight loss.
On a typical week in the stem cell lab there are many different experiments going on. Different people work on their individual projects, but we often collaborate to share ideas and help each other.
You may have heard that a cell-based treatment approach (sometimes referred to as a βstem cell treatmentβ), developed by a company called ReNeuron, is being tested in a clinical trial at Oxford Eye Hospital and other centres in the US and Europe.
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
A research project funded by Retina UK helped pave the way to a new gene therapy that has recently produced encouraging results in two young people with achromatopsia, a condition that causes complete colour-blindness and poor overall vision from birth.
A virtual delegate bag for our online attendees - Professionals' Conference 2024
If you, or a close relative, are living with a genetic sight loss condition, there may be a chance that your children will inherit it.
Did you join either of our Conferences this year? You can read about them inside this edition of Look Forward. Weβve had some fantastic feedback from our delegates so if you werenβt able to attend, you can watch or listen to the recordings from the day on our website.